Eyepoint Pharmaceuticals (EYPT) had the highest return between March 26, 2023 and April 30, 2023 by a small-cap US stock, returning 167.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Eyepoint Pharmaceuticals (EYPT) | 3/26/2023 - 4/30/2023 | 167.23% |
National CineMedia (NCMI) | 3/26/2023 - 4/30/2023 | 141.27% |
Pulse Biosciences (PLSE) | 3/26/2023 - 4/30/2023 | 124.39% |
SS Innovations International Inc Common Stock (SSII) | 3/26/2023 - 4/30/2023 | 116.22% |
GDEV (GDEV) | 3/26/2023 - 4/30/2023 | 91.92% |
Burford Capital (BUR) | 3/26/2023 - 4/30/2023 | 87.34% |
Trevi Therapeutics (TRVI) | 3/26/2023 - 4/30/2023 | 86.96% |
Xeris Pharmaceuticals (XERS) | 3/26/2023 - 4/30/2023 | 73.85% |
X4 Pharmaceuticals (XFOR) | 3/26/2023 - 4/30/2023 | 72.94% |
Phathom Pharmaceuticals (PHAT) | 3/26/2023 - 4/30/2023 | 71.2% |
Oculis Holding AG Ordinary shares (OCS) | 3/26/2023 - 4/30/2023 | 67.12% |
Corvus Pharmaceuticals (CRVS) | 3/26/2023 - 4/30/2023 | 65.54% |
Getty Images (GETY) | 3/26/2023 - 4/30/2023 | 65.3% |
American Coastal Insurance (ACIC) | 3/26/2023 - 4/30/2023 | 65.2% |
Aquestive Therapeutics (AQST) | 3/26/2023 - 4/30/2023 | 61.45% |
Sana Biotechnology (SANA) | 3/26/2023 - 4/30/2023 | 60.79% |
Cimpress (CMPR) | 3/26/2023 - 4/30/2023 | 60.14% |
Mereo BioPharma Group PLC ADR (MREO) | 3/26/2023 - 4/30/2023 | 57.83% |
Avalo Therapeutics (AVTX) | 3/26/2023 - 4/30/2023 | 57.3% |
Bright Minds Biosciences (DRUG) | 3/26/2023 - 4/30/2023 | 53.04% |
Collective Mining (CNL) | 3/26/2023 - 4/30/2023 | 49.59% |
Omeros (OMER) | 3/26/2023 - 4/30/2023 | 49.48% |
ATAI Life Sciences (ATAI) | 3/26/2023 - 4/30/2023 | 48.06% |
IperionX Limited American Depositary Share (IPX) | 3/26/2023 - 4/30/2023 | 47.98% |
Precigen (PGEN) | 3/26/2023 - 4/30/2023 | 47.56% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
